课题基金 / 基金详情

Capturing New Drugs That Selectively Modulate PAR2 Signaling Pathways

Capturing New Drugs That Selectively Modulate PAR2 Signaling Pathways
捕获选择性调节 PAR2 信号通路的新药物
批准号:
nhmrc : 1047759
负责人:
Prof David Fairlie
金额:
$31.28万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2015-12-31

项目摘要

项目成果

Prof David Fairlie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Infection and tissue damage provoke acute inflammatory responses that sometimes continue unchecked, leading to different kinds of debilitating inflammatory diseases and cancers. We have discovered a new class of drugs that bind to a new target on human cells and block undesirable prolonged inflammatory responses. This project tests a new strategy to produce 'cleaner' drugs that act more selectively with fewer side effects against a new target in the treatment of arthritis and other inflammatory diseases, diet-induced obesity and cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Super-resolution platform to accelerate biological and molecular research
  • 批准号:
    LE240100134
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
  • 资助金额:
    $53.09万
  • 财政年份:
    2024
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Compressing small peptides for cell absorption
  • 批准号:
    DP180103244
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $40.43万
  • 财政年份:
    2018
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Combating infectious diseases by harnessing macrophage functions
  • 批准号:
    nhmrc : GNT1125316
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.82万
  • 财政年份:
    2017
  • 负责人:
    Prof David Fairlie
  • 依托单位:
Modulating Protein-Protein Interactions In Disease
  • 批准号:
    nhmrc : GNT1117017
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $86.39万
  • 财政年份:
    2017
  • 负责人:
    Prof David Fairlie
  • 依托单位:
海外基金